콘텐츠로 건너뛰기
Merck
  • Systemic delivery of factor IX messenger RNA for protein replacement therapy.

Systemic delivery of factor IX messenger RNA for protein replacement therapy.

Proceedings of the National Academy of Sciences of the United States of America (2017-02-17)
Suvasini Ramaswamy, Nina Tonnu, Kiyoshi Tachikawa, Pattraranee Limphong, Jerel B Vega, Priya P Karmali, Pad Chivukula, Inder M Verma
초록

Safe and efficient delivery of messenger RNAs for protein replacement therapies offers great promise but remains challenging. In this report, we demonstrate systemic, in vivo, nonviral mRNA delivery through lipid nanoparticles (LNPs) to treat a Factor IX (

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
1,2-Dimyristoyl-sn-glycerol, ≥95%